• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cinacalcet: Addressing the Unmet Clinical Need in the Management of CKD-Mineral and Bone Disorder in Infants on Dialysis.

作者信息

Snauwaert Evelien, Prytuła Agnieszka

机构信息

Department of Pediatric Nephrology and Rheumatology, Ghent University Hospital, ERKNet Center, Ghent, Belgium.

出版信息

Kidney Int Rep. 2024 Jun 10;9(8):2332-2334. doi: 10.1016/j.ekir.2024.06.014. eCollection 2024 Aug.

DOI:10.1016/j.ekir.2024.06.014
PMID:39156150
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11328741/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1829/11328741/bc1d40aeac19/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1829/11328741/bc1d40aeac19/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1829/11328741/bc1d40aeac19/gr1.jpg

相似文献

1
Cinacalcet: Addressing the Unmet Clinical Need in the Management of CKD-Mineral and Bone Disorder in Infants on Dialysis.西那卡塞：解决透析婴儿慢性肾脏病 - 矿物质和骨异常管理中未满足的临床需求。
Kidney Int Rep. 2024 Jun 10;9(8):2332-2334. doi: 10.1016/j.ekir.2024.06.014. eCollection 2024 Aug.
2
Utilization and costs of medications associated with CKD mineral and bone disorder in dialysis patients enrolled in Medicare Part D.参加联邦医疗保险D部分的透析患者中与慢性肾脏病矿物质和骨异常相关药物的使用情况及费用
Am J Kidney Dis. 2014 Nov;64(5):770-80. doi: 10.1053/j.ajkd.2014.04.014. Epub 2014 May 13.
3
Impact of Cinacalcet and Etelcalcetide on Bone Mineral and Cardiovascular Disease in Dialysis Patients.西那卡塞和依特卡塞特对透析患者骨矿物质和心血管疾病的影响。
Curr Osteoporos Rep. 2023 Apr;21(2):193-204. doi: 10.1007/s11914-023-00782-x. Epub 2023 Feb 27.
4
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of cinacalcet in the treatment of CKD-MBD].[慢性肾脏病-矿物质和骨异常（CKD-MBD）。西那卡塞在CKD-MBD治疗中的作用]
Clin Calcium. 2010 Jul;20(7):1089-95.
5
Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).医生对慢性肾脏病-矿物质和骨异常（CKD-MBD）当前评估与治疗的态度调查
Saudi J Kidney Dis Transpl. 2010 Jan;21(1):93-101.
6
Clinical and Practical Use of Calcimimetics in Dialysis Patients With Secondary Hyperparathyroidism.拟钙剂在继发性甲状旁腺功能亢进透析患者中的临床及实际应用
Clin J Am Soc Nephrol. 2016 Jan 7;11(1):161-74. doi: 10.2215/CJN.01760215. Epub 2015 Jul 29.
7
Treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).慢性肾脏病-矿物质和骨异常（CKD-MBD）的治疗。
Intern Med. 2008;47(11):989-94. doi: 10.2169/internalmedicine.47.1051. Epub 2008 Jun 2.
8
Cinacalcet for Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: A Meta-Analysis of Randomized Controlled Trials.西那卡塞治疗慢性肾脏病-矿物质和骨异常：一项随机对照试验的荟萃分析。
Nephron. 2018;139(3):197-210. doi: 10.1159/000487546. Epub 2018 Mar 7.
9
Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis.西那卡塞在接受透析的继发性甲状旁腺功能亢进儿科受试者中的研究。
Pediatr Nephrol. 2020 Sep;35(9):1679-1697. doi: 10.1007/s00467-020-04516-4. Epub 2020 May 4.
10
Cinacalcet use in paediatric dialysis: a position statement from the European Society for Paediatric Nephrology and the Chronic Kidney Disease-Mineral and Bone Disorders Working Group of the ERA-EDTA.西那卡塞在儿科透析中的应用：来自欧洲儿科学肾脏病学会和欧洲透析和移植协会-慢性肾脏病-矿物质和骨异常工作组的立场声明。
Nephrol Dial Transplant. 2020 Jan 1;35(1):47-64. doi: 10.1093/ndt/gfz159.

本文引用的文献

1
Safety and Efficacy of Cinacalcet in Children Aged Under 3 Years on Maintenance Dialysis.西那卡塞对3岁以下维持性透析儿童的安全性和有效性
Kidney Int Rep. 2024 May 7;9(7):2096-2109. doi: 10.1016/j.ekir.2024.04.061. eCollection 2024 Jul.
2
Indoxyl Sulfate Contributes to Impaired Height Velocity in (Pre)School Children.硫酸吲哚酚导致（学龄前）儿童身高增长速度受损。
Kidney Int Rep. 2024 Mar 26;9(6):1674-1683. doi: 10.1016/j.ekir.2024.03.021. eCollection 2024 Jun.
3
Diagnosis and management of mineral and bone disorders in infants with CKD: clinical practice points from the ESPN CKD-MBD and Dialysis working groups and the Pediatric Renal Nutrition Taskforce.
CKD 婴儿矿物质和骨代谢紊乱的诊断和管理：ESPN CKD-MBD 和透析工作组以及儿科肾脏营养工作组的临床实践要点。
Pediatr Nephrol. 2023 Sep;38(9):3163-3181. doi: 10.1007/s00467-022-05825-6. Epub 2023 Feb 14.
4
Hyperparathyroidism Is an Independent Risk Factor for Allograft Dysfunction in Pediatric Kidney Transplantation.甲状旁腺功能亢进是小儿肾移植中移植肾功能障碍的独立危险因素。
Kidney Int Rep. 2022 Oct 28;8(1):81-90. doi: 10.1016/j.ekir.2022.10.018. eCollection 2023 Jan.
5
Cinacalcet use in paediatric dialysis: a position statement from the European Society for Paediatric Nephrology and the Chronic Kidney Disease-Mineral and Bone Disorders Working Group of the ERA-EDTA.西那卡塞在儿科透析中的应用：来自欧洲儿科学肾脏病学会和欧洲透析和移植协会-慢性肾脏病-矿物质和骨异常工作组的立场声明。
Nephrol Dial Transplant. 2020 Jan 1;35(1):47-64. doi: 10.1093/ndt/gfz159.
6
Old and new calcimimetics for treatment of secondary hyperparathyroidism: impact on biochemical and relevant clinical outcomes.用于治疗继发性甲状旁腺功能亢进的新旧钙敏感受体激动剂：对生化指标及相关临床结局的影响
Clin Kidney J. 2018 Feb;11(1):80-88. doi: 10.1093/ckj/sfx125. Epub 2017 Dec 8.
7
Outcome of Patients Initiating Chronic Peritoneal Dialysis During the First Year of Life.婴儿期起始慢性腹膜透析患者的预后。
Pediatrics. 2015 Sep;136(3):e615-22. doi: 10.1542/peds.2015-0980.
8
Survival and clinical outcomes of children starting renal replacement therapy in the neonatal period.新生儿期开始肾脏替代治疗的儿童的生存和临床结局。
Kidney Int. 2014 Jul;86(1):168-74. doi: 10.1038/ki.2013.561. Epub 2014 Feb 5.
9
The bone and mineral disorder of children undergoing chronic peritoneal dialysis.儿童慢性腹膜透析相关的骨矿物质代谢紊乱。
Kidney Int. 2010 Dec;78(12):1295-304. doi: 10.1038/ki.2010.316. Epub 2010 Sep 1.